文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Editorial: Emerging advances in exploiting pulmonary administration for treatment of thoracic diseases.

作者信息

Wu Lina, Lanza Gregory M, Xie Jin, Pan Dipanjan

机构信息

Molecular Imaging Research Center, the Fourth affiliated hospital of Harbin Medical University, Harbin, China.

School of Medicine, Washington University in St. Louis, St. Louis, MO, United States.

出版信息

Front Bioeng Biotechnol. 2025 Apr 25;13:1612172. doi: 10.3389/fbioe.2025.1612172. eCollection 2025.

DOI:10.3389/fbioe.2025.1612172
PMID:40352345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12062074/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dac/12062074/ac0890d03152/FBIOE_fbioe-2025-1612172_wc_sch1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dac/12062074/ac0890d03152/FBIOE_fbioe-2025-1612172_wc_sch1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dac/12062074/ac0890d03152/FBIOE_fbioe-2025-1612172_wc_sch1.jpg

相似文献

[1]
Editorial: Emerging advances in exploiting pulmonary administration for treatment of thoracic diseases.

Front Bioeng Biotechnol. 2025-4-25

[2]
Deep learning diagnostic and severity-stratification for interstitial lung diseases and chronic obstructive pulmonary disease in digital lung auscultations and ultrasonography: clinical protocol for an observational case-control study.

BMC Pulm Med. 2023-6-2

[3]
Diagnosis of interstitial lung diseases: from Averill A. Liebow to artificial intelligence.

J Pathol Transl Med. 2024-1

[4]
Novel Artificial Intelligence-based Technology for Chest Computed Tomography Analysis of Idiopathic Pulmonary Fibrosis.

Ann Am Thorac Soc. 2022-3

[5]
Idiopathic pulmonary fibrosis: Current knowledge, future perspectives and its importance in radiation oncology.

Radiother Oncol. 2021-2

[6]
Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis.

Front Pharmacol. 2022-6-3

[7]
Diagnosis and management of idiopathic pulmonary fibrosis: Thoracic Society of Australia and New Zealand and Lung Foundation Australia position statements summary.

Med J Aust. 2018-2-5

[8]
Artificial intelligence identifies inflammation and confirms fibroblast foci as prognostic tissue biomarkers in idiopathic pulmonary fibrosis.

Hum Pathol. 2021-1

[9]
A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).

Respir Res. 2016-7-22

[10]
Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis.

Lung. 2014-11-9

本文引用的文献

[1]
Inhalable biohybrid microrobots: a non-invasive approach for lung treatment.

Nat Commun. 2025-1-14

[2]
Charge-assisted stabilization of lipid nanoparticles enables inhaled mRNA delivery for mucosal vaccination.

Nat Commun. 2024-11-2

[3]
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models.

Nat Biotechnol. 2025-1

[4]
Recent Developments in Aerosol Pulmonary Drug Delivery: New Technologies, New Cargos, and New Targets.

Annu Rev Biomed Eng. 2024-7

[5]
Nanomedicines for targeted pulmonary delivery: receptor-mediated strategy and alternatives.

Nanoscale. 2024-2-8

[6]
Enhancing bioavailability of natural extracts for nutritional applications through dry powder inhalers (DPI) spray drying: technological advancements and future directions.

Front Nutr. 2023-7-5

[7]
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.

N Engl J Med. 2023-7-20

[8]
An Osimertinib-Perfluorocarbon Nanoemulsion with Excellent Targeted Therapeutic Efficacy in Non-small Cell Lung Cancer: Achieving Intratracheal and Intravenous Administration.

ACS Nano. 2022-8-23

[9]
Pulmonary Delivery of Theranostic Nanoclusters for Lung Cancer Ferroptosis with Enhanced Chemodynamic/Radiation Synergistic Therapy.

Nano Lett. 2022-2-9

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索